Mechanism of Action of Lenalidomide in Hematological Malignancies

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-2-36
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Telomerase Activation in Hematological Malignancies

Genes
Genetics
2016English

Molecular Cytogenetics of Childhood Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Bridging the Gap in Hematological Malignancies

Expert Review of Hematology
Hematology
2012English

I(5)(p10) in Hematological Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2019English

Emerging Concepts of Epigenetic Dysregulation in Hematological Malignancies

Nature Immunology
AllergyImmunology
2016English

Advances in Immunotherapy for Hematological Malignancies

Journal of Nihon University Medical Association
2016English

Treatment of Hematological Malignancies With Glycyrrhizic Acid

Anticancer Research
MedicineCancer ResearchOncology
2017English

Aspergillosis With Hematological Malignancies in Our Facility

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Molecular Study of the Perforin Gene in Familial Hematological Malignancies

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy